8 Results for "

UK-1

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "UK-1" in MCE Product Catalog:

Cat. No.: HY-129558
CAS No.: 151271-53-3
Target:  

HCV

Research Areas:  

Infection Cancer

UK-1 is a cytotoxic metabolite from Streptomyces sp. 517-02 and exerts a wide spectrum of potent anticancer activities [1]. UK-1 also inhibits HCV replication .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-16511
CAS No.: 590368-25-5
Synonyms: WX-671
Target:  

PAI-1 Ser/Thr Protease

Research Areas:  

Infection Cancer

Upamostat (WX-671), a prodrug of WX-UK1, is an orally active serine protease inhibitor. Upamostat inhibits the urokinase-type plasminogen activator (uPA) system, blocking the plasminogen activation process mediated by it, thereby suppressing the invasion, migration and metastasis of tumor cells. Upamostat can be used in the research of metastatic breast cancer and locally advanced pancreatic cancer [1].
loading...
    loading...
Cat. No.: HY-100415
CAS No.: 220355-63-5
Purity:  96.13%
Synonyms: WX-UK1; UKI-1C
Target:  

PAI-1 Ser/Thr Protease

Research Areas:  

Cancer

UKI-1 (WX-UK1) is a potent urokinase-type plasminogen activator (uPA) inhibitor with a Ki of 0.41 μM. UKI-1 is also a low molecular weight serine protease inhibitor. UKI-1 is a potent antimetastatic agent and inhibits the invasive capacity of carcinoma cells [1] .
loading...
    loading...
Cat. No.: HY-114648
CAS No.: 339300-34-4
Target:  

Bacterial

Research Areas:  

Infection Cancer

AJI-9561 is a benzoxazole derivative produced by Streptomyces sp. AJI-9561 exhibits cytotoxicity and antibacterial activity. AJI-9561 inhibits the proliferation of Jurkat T cells and mouse P388 leukemia cells, with its IC50 being 0.88 and 1.63 μM respectively. AJI-9561 can be used for research on anti-cancer and antibacterial properties [1].
loading...
    loading...
Cat. No.: HY-100415S1
Synonyms: WX-UK1-d8 acetate; UKI-1C-d8 acetate
UKI-1-d8 acetate (WX-UK1-d8 acetate) is the deuterium labeled UKI-1 acetate. UKI-1 (WX-UK1) is a potent urokinase-type plasminogen activator (uPA) inhibitor with a Ki of 0.41 μM. UKI-1 is also a low molecular weight serine protease inhibitor. UKI-1 is a potent antimetastatic agent and inhibits the invasive capacity of carcinoma cells [1] .
loading...
    loading...
Cat. No.: HY-16511A
CAS No.: 1191101-18-4
Synonyms: (E)-WX-671
Target:  

Ser/Thr Protease

Research Areas:  

Cancer

(E)-Upamostat ((E)-WX-671) is an E-isomer of Upamostat (HY-16511). Upamostat (WX-671), a prodrug of WX-UK1, is an orally active serine protease inhibitor [1].
loading...
    loading...
Cat. No.: HY-16511AS
Synonyms: (E)-WX-671-d5
(E)-Upamostat-d5 ((E)-WX-671-d5) is the deuterium labeled (E)-Upamostat (HY-16511A). (E)-Upamostat ((E)-WX-671) is an E-isomer of Upamostat (HY-16511). Upamostat (WX-671), a prodrug of WX-UK1, is an orally active serine protease inhibitor [1].
loading...
    loading...
Cat. No.: HY-16512
CAS No.: 798560-68-6
Synonyms: WX-671 hydrogen sulfate
Target:  

PAI-1 Ser/Thr Protease

Research Areas:  

Cancer

Upamostat (WX-671) hydrogen sulfate, a prodrug of WX-UK1 (HY-100415), is an orally active serine protease inhibitor. Upamostat hydrogen sulfate inhibits the urokinase-type plasminogen activator (uPA) system, blocking the plasminogen activation process mediated by it, thereby suppressing the invasion, migration and metastasis of tumor cells. Upamostat hydrogen sulfate can be used in the research of metastatic breast cancer and locally advanced pancreatic cancer [1].
loading...
    loading...